NeuBase Therapeutics, Inc. (NBSE) received a notice from Nasdaq regarding non-compliance with listing requirements due to a delayed Annual Report filing. The company has until June 3, 2024, to submit a compliance plan and potentially until September 30, 2024, to regain compliance.